tiprankstipranks
Trending News
More News >
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market

ArriVent BioPharma, Inc. (AVBP) Cash flow

Compare
56 Followers

ArriVent BioPharma, Inc. Cash Flow

AVBP's free cash flow for Q3 2025 was $-35.80M. For the 2025 fiscal year, AVBP's free cash flow was decreased by $-14.37M and operating cash flow was $-35.80M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -70.21M$ -55.84M$ -43.63M$ -12.59M
Investing Cash Flow
$ -192.47M$ 0.00$ 0.00$ -40.00M
Financing Cash Flow
$ 186.58M$ 42.86M$ 169.72M$ 89.87M
End Cash Position
$ 74.29M$ 150.39M$ 163.37M$ 37.28M
Free Cash Flow
$ -70.21M$ -55.84M$ -43.63M$ -12.59M
Currency in USD

ArriVent BioPharma, Inc. Cash Flow